ImmunXperts s.a. a start-up located in Gosselies (Belgium) and specializing in the development of proprietary and innovative methods to assess the immunogenicity of novel biotherapeutics and biosimilars has raised USD 1 million in equity and bank [...]
Euroscreen, a Belgian drug discovery and development company providing first-in-class small molecule drug candidates for therapeutics areas such as hormonal disorders, inflammation and neurodegenerative diseases, announced an exclusive world-wide research collaboration and licensing agreement with Merck [...]
Pluriomics, an emerging biotech company located in Leiden (The Netherlands) and specializing in the delivery of innovative cardiomyocyte models, has raised €4 million in a Series A round to strengthen its R&D and commercial team in [...]
Bone Therapeutics – a Walloon cell therapy company specialized in bone fracture repair and prevention – shifts up a gear and raises EUR 32.2 million in a 2.5x oversubscribed successful IPO on Brussels and Paris Euronext [...]